These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11858373)

  • 1. The prevalence and molecular basis of beta-thalassemia in Isparta province and region.
    Tunç B; Cetin H; Gümrük F; Istanbullu B; Yavrucuoğlu H; Kurt U; Genç H
    Turk J Pediatr; 2002; 44(1):18-20. PubMed ID: 11858373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey.
    Gurbak M; Sivasli E; Coskun Y; Bozkurt AI; Ergin A
    Pediatr Hematol Oncol; 2006; 23(5):419-25. PubMed ID: 16728362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and molecular analysis of β-thalassemia in Adiyaman, Turkey.
    Genc A; Tastemir Korkmaz D; Buyukleyla M; Celiker M
    Hemoglobin; 2012; 36(2):131-8. PubMed ID: 22356097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
    Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
    Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional distributions of beta-thalassemia mutations in Turkey.
    Atalay EO; Cirakoğlu B; Dinçolç G; Atalay A; Kilinç Y; Aytekin H; Yüregir GT; Arpaci A; Bermek E; Aksoy M
    Int J Hematol; 1993 Jun; 57(3):207-11. PubMed ID: 8364184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'NESTROFT'--an effective screening test for beta thalassemia trait.
    Manglani M; Lokeshwar MR; Vani VG; Bhatia N; Mhaskar V
    Indian Pediatr; 1997 Aug; 34(8):702-7. PubMed ID: 9492398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM; El-Khatib FF; Ayesh S
    Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey.
    Guler E; Garipardic M; Dalkiran T; Davutoglu M
    Pediatr Hematol Oncol; 2010 Nov; 27(8):608-13. PubMed ID: 20795773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran.
    Kiani AA; Mortazavi Y; Zeinali S; Shirkhani Y
    Hemoglobin; 2007; 31(3):343-9. PubMed ID: 17654071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq.
    Al-Allawi NA; Jubrael JM; Hughson M
    Hemoglobin; 2006; 30(4):479-86. PubMed ID: 16987803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
    Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
    Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test.
    El-Beshlawy A; Kaddah N; Moustafa A; Mouktar G; Youssry I
    East Mediterr Health J; 2007; 13(4):780-6. PubMed ID: 17955759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-thalassemia mutations in Rome. A high frequency of the IVSII-745 allele in subjects of latium origin.
    Massa A; Cianciulli P; Cianetti L; Iazzone R; Cenci A; Sorrentino F; Franco G; Pecci G; Papa G; Peschle C
    Haematologica; 1994; 79(3):256-8. PubMed ID: 7926974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology investigation of beta-thalassemia in Zhongshan City, Guangdong Province, People's Republic of China.
    Zhang CM; Wang Y; Gao LS; Gao JH; He XL; Feng HJ; Liao JL
    Hemoglobin; 2010; 34(1):55-60. PubMed ID: 20113289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of beta-thalassaemia in subcastes of Indian Sindhis: Results from a two-phase survey.
    Jawahirani A; Mamtani M; Das K; Rughwani V; Kulkarni H
    Public Health; 2007 Mar; 121(3):193-8. PubMed ID: 17196230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of beta-thalassemia trait and abnormal hemoglobins in the province of Adıyaman, Turkey.
    Genc A; Tastemir Korkmaz D; Urhan Kucuk M; Rencuzogullari E; Atakur S; Bayram S; Onderci M; Koc T; Aslan S; Mutalip A; Faruk M; Sevgiler Y; Tuncdemir A
    Pediatr Hematol Oncol; 2012 Oct; 29(7):620-3. PubMed ID: 22897698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalassemias and other hemoglobinopathies in the Republic of Macedonia.
    Efremov GD
    Hemoglobin; 2007; 31(1):1-15. PubMed ID: 17365000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
    Mamtani M; Das K; Jawahirani A; Rughwani V; Kulkarni H
    J Med Screen; 2007; 14(4):169-73. PubMed ID: 18078560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.